All the analyst reiterating is because they are " all in" now. As I am….YIPPPEEEEEEEE. They were buying a lot of shares on dips the last 4 months but those days are over. Weak hands are all out and great news is coming.
He has a PHD but not a sure what ,if any medical background that he has. Spent most his type closely following oncology. You don't need to be a genius to pick Cemp now. Soli is already proven…..and its a drug that cures. No brainer really.
Very active Pro shorts were smart to short at 47 for a trade. It popped on an upgrade and short covering. Its the retail shorts that will get burnt. They are to stubborn and hate to take a loss. Next thing they know, they are bankrupt.
Shorts making an out out defense of holding it under the key number of 46. It will be interesting to watch. Maybe Monday there will be news about Gono etc. If it is not today it will be soon. No worries.
I saw a 40,000 phantom AH trade 2 nights ago. And I noticed shorts added a bit on the last pop. What a bunch of dummies…..lol. Cemp/Soli is the "real" deal . Prabha had said if they could monetize its predecessor that it would be 4-7 billion.
1 trade of 3200 shares at 4:10 PM. Either someone desperately needed cash or shorts painting the tape with a small block. Possibly an earlier trade that closed after hrs.
The way the trials are set up, Cemp is privy to certain patient data. I believe its due to resistance importance. She certainly does know how its going and actually said so in not so many words during her last speech. Oral was hulkian in effectiveness for a macrolide so IV isn't really a problem and the PPS today confirms this.
This guy is/was a director on many bio boards. He was an Independent director for Cempra. I believe he is still managing partner of Aisling Capital LLC. He sold out on many of his shares of a few bio's lately. I hope he earned his big payday for Cemp. Im not sure he did much of anything since he is a gynecologist. . He sure had a knack of picking the right comanys to be directors for. Take the money and run kind of guy. He left a lot of money on the table with Cemp though.
Has to be more than the fact they can get easy financing. Me thinks Cemp is getting sold sooner than we thought..
Yes. I remember when it was only you,me and only a cple of others on the board. Good time,good times…lol Knowing we had a big winner.
Lets look back…….. I told everyone that price targets were all intentionaly low so the funds could load up on the stock. I said to buy every time it hit the low 30's. I said I would take $ from my Cemp trading account and put it with "all in" long in July. Whats next ? Gono and IV news,upgrades etc. will drive Cemp in to the 60's and buy out $100 or above. Cheers
I haven't seen anything new from Ritu Baral on Cemp. Her initial $35 target was pretty lame but she is famous for her low price targets. She was at Canaccord for a long time and had a plus 23% yr annual win. She recently joined Cowen . She has my respect as she does have a degree in biological science and she isn't a sheep. She follows some bio that is off most analysts radar . Her most recent picks are Cytk and Qure. Cemp broke out on some nice volume last week. Congrats to all.
Oral Soli would get approved if filed. Im not sure what all you peeps are talking about. With oral a lock ( and most likely everything else)…..they switched easily to some nice financing.
All mentioned are approved for the treatment of acute bacterial skin and skin structure infections. Your name states"long" but you seem like a clueless short.